Insmed achieved positive phase 2b results for TPIP in PAH. Click here to find out why INSM stock is a Strong Buy.

TAMPA, FL / ACCESS Newswire / June 10, 2025 / Full Alliance Group, Inc. (OTC PINK:FAGI) today announced major strides in the commercial development of its recently formed subsidiary, Aquaox Pure Solut ...

Algae oil is an alternative to fish oil, which is rich in omega-3 fatty acids. Here's what you need to know about the ...

From listeria outbreaks to product pulls, these ice cream recalls exposed safety failures across major brands. Many led to ...

The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and ...

(“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Adolescents face significant barriers to obesity medication access, despite a surge in prescriptions. Discover the ...

As the anti-seed-oil movement picks up steam, many restaurants are leaning on ”no seed oils” as part of their messaging and ...

After months of testing, we landed on 73 winners: protein bars, stir-fry sauces, a bevy of tinned fish, instant coffee and ...

The global population is aging rapidly, with the number of people aged 65 and older expected to double by 2050. This demographic shift is driving a s ...